Associate or Professor of Clinical Pediatrics (Transplantation and Cellular Therapy)-CHLAApply (https://facultypositions.usc.edu/FAS/application/position?postingId=REQ20113359) Keck School of Medicine Faculty Los Angeles, California

The University of Southern California (USC), founded in 1880, is the largest private employer in the City of Los Angeles. As an employee of USC, you will be a part of a world-class research university and a member of the "Trojan Family," which is comprised of the faculty, students and staff that make the university what it is.

The Keck School of Medicine (KSOM) of the University of Southern California (USC) and Children’s Hospital Los Angeles (CHLA) in the Department of Pediatrics in the Division of Hematology-Oncology, are actively seeking a full-time faculty member for the position of Transplantation and Cellular Therapy Medical Director.

The successful candidate will hold a primary academic appointment in the Department of Pediatrics at the University of Southern California (USC) Keck School of Medicine at the level of Associate Professor or Professor of Clinical Pediatrics. In this position, he/she is expected to serve primarily as the Medical Director of the Transplantation and Cellular Therapy service with the remainder of the time dedicated to research and administration.

CHLA and USC are equal opportunity, affirmative action employers. The division greatly values diversity and is committed to building a vibrant and culturally diverse community of faculty that best reflects the patients and families that we serve. Individuals from underrepresented groups in medicine are especially encouraged to apply.

Apply here and for further inquiries, contact:

Neena Kapoor, MD

Interim Section Head, Transplantation & Cellular Therapy

Director, Transplantation and Cellular Therapy Laboratory

Division of Hematology-Oncology

Children’s Hospital Los Angeles

Professor of Pediatrics

Keck School of Medicine

University of Southern California

Email:nkapoor@chla.usc.edu

REQ20113359 Posted Date: 02/22/2022